Inventor · disambiguated record
Nadine Paiement
Also filed as: PAIEMENT NADINE
20 granted patents·30 pending applications·220 citations·filing 2006–2024
94Inventor score
Top patents by PatentIndex Score
50 records- 0198US7674479B2Sustained-release bupropion and bupropion/mecamylamine tabletsINTELGENX CORP·Filed 2007·Granted Mar 9, 2010·137 cites·10 claims
- 0294US10272038B2Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2017·Granted Apr 30, 2019·9 cites·28 claims
- 0393US11471406B2Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2020·Granted Oct 18, 2022·3 cites·20 claims
- 0492US9668970B2Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2014·Granted Jun 6, 2017·11 cites·20 claims
- 0590US11033493B2Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2018·Granted Jun 15, 2021·5 cites·20 claims
- 0690US10828254B2Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2018·Granted Nov 10, 2020·4 cites·20 claims
- 0790US8735374B2Oral mucoadhesive dosage formZERBE HORST G·Filed 2010·Granted May 27, 2014·19 cites·8 claims
- 0889US10722476B2Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2018·Granted Jul 28, 2020·3 cites·12 claims
- 0988US11602504B2Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2019·Granted Mar 14, 2023·4 cites·17 claims
- 1086US9949934B1Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2016·Granted Apr 24, 2018·5 cites·3 claims
- 1185US11648212B2Loxapine film oral dosage formINTELGENX CORP·Filed 2018·Granted May 16, 2023·3 cites·12 claims
- 1283US10610528B2Solid oral film dosage forms and methods for making sameINTELGENX CORP·Filed 2017·Granted Apr 7, 2020·3 cites·10 claims
- 1383US8703191B2Controlled-release pharmaceutical tabletsZERBE HORST G·Filed 2007·Granted Apr 22, 2014·3 cites·10 claims
- 1483US2025120908A1Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2024·Application pending·0 cites
- 1581US9717682B2Solid oral film dosage forms and methods for making sameINTELGENX CORP·Filed 2013·Granted Aug 1, 2017·3 cites·30 claims
- 1681US8691272B2Multilayer tabletZERBE HORST G·Filed 2006·Granted Apr 8, 2014·4 cites·1 claims
- 1779US12156937B2Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2022·Granted Dec 3, 2024·0 cites·20 claims
- 1878US9301948B2Instantly wettable oral film dosage form without surfactant or polyalcoholINTELGENX CORP·Filed 2014·Granted Apr 5, 2016·4 cites·20 claims
- 1972US2023201130A1Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2023·Application pending·0 cites
- 2068US2023248660A1Method of preparing loxapine film oral dosage formINTELGENX CORP·Filed 2023·Application pending·0 cites
- 2167US11957785B2Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2021·Granted Apr 16, 2024·0 cites·20 claims
- 2267US2022362164A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2022·Application pending·0 cites
- 2367US2022395452A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2022·Application pending·0 cites
- 2466US2024139101A1Advanced oral film formulationsINTELGENX CORP·Filed 2023·Application pending·0 cites
- 2566US2019247505A1Film dosage forms containing amorphous active agentsINTELGENX CORP·Filed 2019·Application pending·0 cites
- 2662US2019209459A1Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2019·Application pending·0 cites
- 2761US2023225965A1Oral films with flavor entrapmentINTELGENX CORP·Filed 2023·Application pending·0 cites
- 2861US2019290595A1Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2019·Application pending·0 cites
- 2959US2019133925A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2018·Application pending·0 cites
- 3059US2014065217A1Multilayer tabletZERBE HORST G·Filed 2013·Application pending·0 cites
- 3159US2023404937A1Novel disintegration oral film formulation with a controlled or sustained active releaseINTELGENX CORP·Filed 2023·Application pending·0 cites
- 3259US2007128272A1Multi-vitamin and mineral supplementZERBE HORST G·Filed 2006·Application pending·0 cites
- 3358US2018250240A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2018·Application pending·0 cites
- 3457US12440472B2Stable tryptamine oral filmsINTELGENX CORP·Filed 2022·Granted Oct 14, 2025·0 cites·18 claims
- 3557US2024245603A1High loading oral film formulationINTELGENX CORP·Filed 2022·Application pending·0 cites
- 3657US2016324773A1Film dosage forms containing amorphous active agentsINTELGENX CORP·Filed 2016·Application pending·0 cites
- 3755US12303501B2Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2019·Granted May 20, 2025·0 cites·20 claims
- 3854US2016243036A1Film dosage forms containing amorphous active agentsINTELGENX CORP·Filed 2015·Application pending·0 cites
- 3954US2020215063A1Solid oral film dosage forms and methods for making sameINTELGENX CORP·Filed 2020·Application pending·0 cites
- 4053US2024189331A1Novel tryptamine oral film formulationINTELGENX CORP·Filed 2022·Application pending·0 cites
- 4150US2020138885A1Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2019·Application pending·0 cites
- 4249US2019314293A1Loxapine film oral dosage formINTELGENX CORP·Filed 2019·Application pending·0 cites
- 4349US2019231685A1Antihistamine oral film dosage form and method of administrating sameINTELGENX CORP·Filed 2019·Application pending·0 cites
- 4447US2011136815A1Solid oral film dosage forms and methods for making sameZERBE HORST·Filed 2010·Application pending·0 cites
- 4545US2018078549A1Solid oral film dosage forms and methods for making sameINTELGENX CORP·Filed 2017·Application pending·0 cites
- 4645US2018110724A1Film dosage form with multimodal and particle size distributionsINTELGENX CORP·Filed 2017·Application pending·0 cites
- 4740US2017216220A1Loxapine film oral dosage formINTELGENX CORP·Filed 2016·Application pending·0 cites
- 4839US2011263606A1Solid oral dosage forms comprising tadalafilZERBE HORST·Filed 2011·Application pending·0 cites
- 4936US2017258710A1Montelukast transmucosal filmINTELGENX CORP·Filed 2016·Application pending·0 cites
- 5034US2016220480A1Oral dosage film exhibiting enhanced mucosal penetrationINTELGENX CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nadine Paiement files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →